Remove 2017 Remove FDA Remove Governance
article thumbnail

Public Health Product Hops

Bill of Health

Regulatory and patent exclusivity periods govern the timing of generic entry, and because market share and revenue is often quickly lost upon market entry of generic drugs, extending market exclusivity for any duration can be extremely profitable. Could Congress or the FDA have incentivized the manufacturer to initiate the switch much sooner?

article thumbnail

EU and US Regulatory Challenges Facing AI Health Care Innovator Firms

Bill of Health

Beyond the health care sector-specific Medical Devices Regulation (EU) 2017/745 (MDR) and the In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746 (IVDR), this mix of AI & Data related regulatory requirements stems from a series of generalized, cross-sectoral EU laws of the last 5 years. The sectorialism of the U.S.

FDA 288
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AI roundup: HEALWELL AI buys LLMs, Forward to roll out staffless health kiosks

Healthcare It News

Companies are expanding their reach with artificial intelligence through acquisitions, investments and government approvals on a near-daily basis. " FDA clears Lunit breast cancer screening algorithm Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, announced Tuesday that the U.S.

FDA 283
article thumbnail

Physician venture investor talks telehealth, digital therapeutics, Medicaid tech

Healthcare It News

Virtual visits were selected five times more often for anxiety and depression complaints than in-person – and this was for pre-pandemic encounters between 2015 and 2017. Fortunately, government, investors and startups are working together to close some of these care gaps. billion that year to $5.1

Medicaid 358
article thumbnail

A Brief Quantum Medicine Policy Guide

Bill of Health

Devices must primarily comply with Regulations (EU) 2017/745 on Medical Devices and 2017/746 on In Vitro Diagnostic Medical Devices. The EU AI Act , proposed EU AI Liability Directive , and laws under the European Strategy for Data , such as the Data Governance Act , may also play roles. The regulatory landscape in the U.S.

FDA 100
article thumbnail

AI’s Ability to Manipulate Decision Making Requires a Moratorium on Its Use in Obtaining Consent for Biomedical Research

Bill of Health

The federal government’s commitment to assuring that participants in human subject research provide fully informed consent dates back to the U.S In 2017, Congress acted again to update the Common Rule and strengthen the provisions related to consent. While the U.S.

article thumbnail

Biotech Startup Obatala Sciences Raises $3M for Organ-on-a-Chip for Research

HIT Consultant

These solutions, provided to pharmaceutical companies, government labs, and researchers, are designed to accelerate the study and prevention of diseases in the fields of obesity, diabetes, cancer, and regenerative medicines. Funding Accelerates Commercialisation of Research-Enabling Solutions.

FDA 98